Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
Abstract Background Prevention and early detection of colorectal cancer (CRC) is a global priority, with many countries conducting population-based CRC screening programs. Although colonoscopy is the most accurate diagnostic method for early CRC detection, adherence remains low because of its invasi...
Main Authors: | Chang Woo Kim, Hyunjin Kim, Hyoung Rae Kim, Bong-Hyeon Kye, Hyung Jin Kim, Byung Soh Min, Tae Jeong Oh, Sungwhan An, Suk-Hwan Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01759-9 |
Similar Items
-
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
by: Yoon Dae Han, et al.
Published: (2019-03-01) -
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
by: Tae Jeong Oh, et al.
Published: (2017-12-01) -
Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets
by: Julia Oto, et al.
Published: (2023-06-01) -
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
by: Zhang W, et al.
Published: (2021-04-01) -
SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
by: Zhang W, et al.
Published: (2022-05-01)